Previous
Previous

Looking for differences: in vitro isolation of hCDKL5-specific antibody fragments and set-up of a method to quantify hCDKL5 and possibly distinguish between its isoforms.

Next
Next

Genetic models to progress treatments for IQSEC2 related pharmacoresistant epilepsy.